Top 20 biopharma kick off 9.6% market cap surge in Q1 2024 amid Medicare price talks
Some companies, however, reported a market capitalisation decline, including Gilead Sciences and Roche.
Stay updated with breaking news from Pharma Intelligence. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Some companies, however, reported a market capitalisation decline, including Gilead Sciences and Roche.
The AI and computing revolution is ushering in a new era of drug development that is poised to be better, faster and cheaper.
As per the report by Fortune Business Insights, the global biopharmaceutical CMO market size is projected to reach USD 26.49 billion in 2028, at a CAGR of...
Dublin, Nov. 17, 2023 (GLOBE NEWSWIRE) -- The
Some industries may be struggling to convince the market of their relevance after the pandemic, but Informa is making its case successfully. The events jugg